U.P.A Tirzepatide 30mg Weight Loss Vial - Self-Mix

U.P.A Tirzepatide 30mg Weight Loss Vial - Self-Mix

The U.P.A Tirzepatide 30mg Weight Loss Vial offers 30mg of high-purity tirzepatide in a self-mix format, ideal for individuals

seeking advanced fat loss, appetite control, and improved metabolic health. As a dual GIP and GLP-1 receptor agonist, this

tirzepatide weight loss vial enhances metabolic function to reduce cravings, promote calorie reduction, and regulate insulin,

providing a powerful weight management solution in South Africa.

Q What Is Tirzepatide?

Tirzepatide is a novel compound developed for Type 2 Diabetes and obesity management. It activates both GIP and GLP-1

receptors, which:

• Stimulate insulin secretion

• Suppress glucagon production

• Slow gastric emptying

• Reduce appetite and calorie intake

FDA-approved in 2022, tirzepatide is the active ingredient in Mounjaro®, showing superior weight loss efficacy compared to

GLP-1-only agents like semaglutide.

How Does the U.P.A Tirzepatide 30mg Vial Work?

The U.P.A Tirzepatide 30mg vial promotes weight loss through:

• Hunger Control: Reduces appetite via dual receptor activation.

• Extended Satiety: Delays digestion for prolonged fullness.

• Glucose Regulation: Enhances insulin sensitivity.

• Fat Loss Support: Facilitates significant weight reduction.

Clinical trials report up to 20% body weight loss, making this tirzepatide weight loss vial a top-tier option.

VKey Benefits of U.P.A Tirzepatide 30mg Vial

• Superior Weight Loss: Achieves up to 20% body weight reduction.

•2 Non-Stimulant: Gentle on the system, no jitters.

• Metabolic Health: Improves glucose and insulin control.

Self-Mix Dosing: Customizable administration.

TVersatile: ldeal for obesity management and fitness goals.

How to Use the U.P.A Tirzepatide 30mg Vial

• Preparation & Administration:

• Reconstitute the tirzepatide weight loss vial with bacteriostatic water.

• Draw the dose with an insulin syringe.

• Inject subcutaneously, rotating sites.

• Schedule: Weekly administration.

•Note: Follow medical advice for dosing.